Meet & Match Virus-based Technologies
Date
09.30 am - 05.00 pm
Address
ITZ Plus
Hubertus-Liebrecht-Str. 39
88400 Biberach an der Riß
Organiser
BIOPRO and Fraunhofer IGB
Contact
Charlotte Schlett
Phone: +49 (0) 711 218185 84
Email: schlett(at)bio-pro.de
BIOPRO Baden-Württemberg and the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB jointly invite you to the “Meet & Match Virus-based Technologies.” Look forward to an event that fosters new ideas, stimulates fresh perspectives, and creates opportunities for new partnerships.
Meet & Match – Focusing on Expert Exchange and Collaboration
The Meet & Match is all about professional dialogue and networking. The spotlight is on current innovations and developments in virus-based technologies – from fundamental concepts and the identification of promising viral therapy candidates to clinical development, as well as cutting-edge approaches in process design and production.
Across three thematic sessions, leading experts will share their insights, experiences, and perspectives, providing valuable impulses for further exchange:
- Virus-based Technologies: Concepts and Platforms
- Virus-based Therapies: Lead Candidates from Discovery to Clinical Developments
- Enabling Technologies for Process Development, Manufacturing and Analytics
Participants are invited to present their own cooperation ideas, technology innovations, or partnership opportunities during a dedicated Pitch Session. Proposals can be submitted via the Call for Speakers in the registration form – an ideal opportunity to establish new contacts and initiate collaborations.
The number of presentation slots is limited and primarily aimed at representatives from research and industry working in R&D or production. Applications are open until May 6, 2026, via the event registration form. Final selection of talks will be made by the organisers.
In addition to inspiring presentations and expert impulses, the Meet & Match offers plenty opportunities for personal conversation, networking, and exchange on emerging developments and shared visions for the future. The event language is English.
Evening Event: VBT Reloaded – Strategic Dialogue and Regional Development
Following the Meet & Match, Fraunhofer IGB invites participants to an exciting evening event. Under the title “VBT Reloaded: Connecting Science and Industry in the BioPharma Cluster South Germany” this gathering sets a clear signal for the strategic advancement of the Biberach region and promotes stronger collaboration between science, biotech, and industry in the fields of virus-based therapies, ATMPs, and biologics.
A highlight of the evening will be a keynote by Prof. Jochen Maas, former Head of Research at Sanofi-Aventis. In his talk, Prof. Maas will explore the opportunities and challenges of biotechnology in Germany and share insights on innovation capacity, translational research, and competitiveness.
The program also features a moderated panel discussion with regional experts, who will examine key drivers, cooperation potential, and perspectives for further developing this dynamic field.
The language of this evening event is German. Further information about the evening program is available on the Fraunhofer IGB website.
Our Vision
The Meet & Match fosters expert exchange, knowledge sharing, and networking between research and industry. It provides a platform for discussing new ideas and innovations in virus-based technologies. The evening event “VBT Reloaded” complements this with strategic perspectives and a shared vision for future collaboration.
Registration:
The event will take place in Biberach. Participation in both the Meet & Match and the evening event is free of charge. For organisational reasons, prior registration is required. Registration for both parts of the event can be completed via the same online registration form.
Program Meet&Match Virus-based Technologies
| 10:30 a.m. | Networking Coffee |
| 11:00 a.m. | Words of Welcome |
| 11:10 a.m. | Session 1: Virus-based Technologies: Concepts and PlatformsImmunovirotherapy contributing to multimodal therapy of highly aggressive NUT carcinomas Prof. Dr. Ulrich Lauer, University Hospital Tübingen tba Prof. Dr. Jan Münch, Ulm University Hospital tba |
| 12:00 p.m. | Networking Coffee |
| 12:30 p.m. | Session 2: Virus-based Therapies: Lead Candidates from Discovery to Clinical Developmenttba Dr. Jennifer Altomonte, Fusix Biotech GmbH Xenotropic latency as a novel tool for durable vaccines: An MCMV-based vaccine elicits long-lived and broad protection in Syrian hamsters Dr. Henning Jacobsen, Helmholtz Centre for Infection Research tba |
| 01:30 p.m. | Lunch |
| 02:30 p.m. | Session 3: Enabling Technologies for Process Development, Manufacturing and AnalyticsContinuous Manufacturing from a mid-sized CDMO Perspective – Innovation Driver or Stumbling Block Thilo Grob, Rentschler Biopharma SE Process Analytical Technology (PAT) during VLP processing Prof. Dr. Jürgen Hubbuch, Karlsruhe Institute of Technology Smarter Cells for Better Viral Vector Manufacturing Prof. Dr. Kerstin Otte, Biberach University of Applied Sciences tba |
| 03:30 p.m. | Pitch-Session |
| 04:00 p.m. | Networking Coffee |
Program evening event "VBT Reloaded: Connecting Science and Industry in the BioPharma Cluster South Germany"
| 05:00 p.m. | Words of Welcome Prof. Dr. Petra Kluger, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB |
| 05:10 p.m. | Keynote Prof. Dr. Jochen Maas, former CEO Research & Development Sanofi-Aventis Deutschland GmbH |
| 05:40 p.m. | Panel discussion "Short paths, strong impact: How a regional cluster can drive new impulses for virus-based therapies and biologics" Dr. Ralf Amann, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Prime Vector Technologies GmbH Prof. Dr. Uwe Bücheler, BioPharma Cluster South Germany e. V. Dr. Thomas Reith, Boehringer Ingelheim International GmbH |
| 06:15 p.m. | Networking Dinner |
| 09:00 p.m. | End of Event |